These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 12123423)
1. Safety and tolerability of caspofungin acetate in the treatment of fungal infections. Sable CA; Nguyen BY; Chodakewitz JA; DiNubile MJ Transpl Infect Dis; 2002 Mar; 4(1):25-30. PubMed ID: 12123423 [TBL] [Abstract][Full Text] [Related]
2. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis. Keating G; Figgitt D Drugs; 2003; 63(20):2235-63. PubMed ID: 14498760 [TBL] [Abstract][Full Text] [Related]
3. Caspofungin acetate for treatment of invasive fungal infections. Pacetti SA; Gelone SP Ann Pharmacother; 2003 Jan; 37(1):90-8. PubMed ID: 12503942 [TBL] [Abstract][Full Text] [Related]
5. Caspofungin: first approved agent in a new class of antifungals. Johnson MD; Perfect JR Expert Opin Pharmacother; 2003 May; 4(5):807-23. PubMed ID: 12740003 [TBL] [Abstract][Full Text] [Related]
9. Caspofungin: a review of its use in the treatment of fungal infections. McCormack PL; Perry CM Drugs; 2005; 65(14):2049-68. PubMed ID: 16162025 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin. Maschmeyer G; Glasmacher A Mycoses; 2005 Jul; 48(4):227-34. PubMed ID: 15982202 [TBL] [Abstract][Full Text] [Related]
12. Caspofungin: a major breakthrough in treatment of systemic fungal infections. Agarwal MB; Rathi SA; Ratho N; Subramanian R J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012 [TBL] [Abstract][Full Text] [Related]
13. Caspofungin: the first representative of a new antifungal class. Letscher-Bru V; Herbrecht R J Antimicrob Chemother; 2003 Mar; 51(3):513-21. PubMed ID: 12615851 [TBL] [Abstract][Full Text] [Related]
14. A comparative evaluation of properties and clinical efficacy of the echinocandins. Kim R; Khachikian D; Reboli AC Expert Opin Pharmacother; 2007 Jul; 8(10):1479-92. PubMed ID: 17661730 [TBL] [Abstract][Full Text] [Related]
15. Caspofungin: new indication. Same indications in children as in adults. Prescrire Int; 2009 Aug; 18(102):155. PubMed ID: 19743569 [TBL] [Abstract][Full Text] [Related]
16. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. Walsh TJ; Teppler H; Donowitz GR; Maertens JA; Baden LR; Dmoszynska A; Cornely OA; Bourque MR; Lupinacci RJ; Sable CA; dePauw BE N Engl J Med; 2004 Sep; 351(14):1391-402. PubMed ID: 15459300 [TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases. Arathoon EG; Gotuzzo E; Noriega LM; Berman RS; DiNubile MJ; Sable CA Antimicrob Agents Chemother; 2002 Feb; 46(2):451-7. PubMed ID: 11796357 [TBL] [Abstract][Full Text] [Related]
18. The first echinocandin: caspofungin. Cornely OA; Schmitz K; Aisenbrey S Mycoses; 2002; 45 Suppl 3():56-60. PubMed ID: 12690973 [TBL] [Abstract][Full Text] [Related]
20. The use of caspofungin in HIV-infected individuals. Waters L; Nelson M Expert Opin Investig Drugs; 2007 Jun; 16(6):899-908. PubMed ID: 17501701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]